Prosecution Insights
Last updated: November 04, 2026
Application No. 18/825,692

WEARABLE ULTRASOUND SYSTEM AND METHOD

Final Rejection §102§103§112
Filed
Sep 05, 2024
Priority
Mar 21, 2016 — provisional 62/311,110 +2 more
Examiner
PENG, BO JOSEPH
Art Unit
3797
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Isono Health Inc.
OA Round
2 (Final)
70%
Grant Probability
Favorable
3-4
OA Rounds
1y 5m
Est. Remaining
83%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allowance Rate
543 granted / 780 resolved
At TC average
Moderate +14% lift
Without
With
+13.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
46 currently pending
Career history
833
Total Applications
across all art units

Statute-Specific Performance

§101
8.3%
-31.7% vs TC avg
§103
42.3%
+2.3% vs TC avg
§102
14.3%
-25.7% vs TC avg
§112
29.2%
-10.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 780 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 2-16 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. The Examiner is unable to find “wherein the transducer is rotated axially relative to the scanning assembly” from the Originally filed Specs. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-16 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In re claim 1, it is unclear what the metes and bounds of “wherein the transducer is rotated axially relative to the scanning assembly” are. How is axial direction defined? How is relative to scanning assembly being defined? In a 3D world, any axis can be axially relative to. Applicant has failed to limit the scope of axially relative with respect to a specific directional placement of the scanning assembly. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 2-15 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Michael Berman (US 2013/0267850, hereinafter Berman ‘850). In re claim 2, Berman ‘850 teaches a method of imaging tissue, the method comprising: scanning, using a transducer enclosed in a scanning assembly coupled to a wearable housing that is configured to secure to a user's body (0124, fig. 2, 30), a first portion of tissue at a first position relative to the user (fig. 10a-d), wherein the transducer is configured to direct a beam at the user's skin (fig. 10a-d, 0077, 0085, 0139, 0235), wherein the transducer is rotated axially relative to the scanning assembly (fig. 10, para 0125-0128, 85 is axial rotation for transducer 50, note that transducer can be rotated in 85, 86, 87, which are x, y, z, direction and one of them could be the axial rotation, Applicant has failed to limit the scope of axial rotation); and moving the transducer within the scanning assembly to a second position along a scan path relative to the user and scanning at least one of the first portion of tissue and a second portion of tissue (fig. 10a-d, 50 can be moved; 0127, many path shown by arrows 85, 86, 87). In re claim 3, Berman ‘850 teaches wherein the second position is in a different plane relative to the first position (fig. 10, not that any new 86 position with a rotated 85 will be in a different plant than the first position). In re claim 4, Berman ‘850 teaches wherein the second position is based on identifying anatomical data or user-specific tissue characteristics (0123, note that this claim does not exclude that the first position is also based on user-specific tissue characteristic; hence, it is up to the user to decide what parameter to input for the patient’s tissue of interest from the start to finish). In re claim 5, Berman ‘850 teaches wherein the tissue is imaged by combining the scan of the first portion of tissue at the first position relative to the user and the scan of the second portion of tissue at the second position relative to the user (fig. 7, fig. 10, 0125, 0127, 0128, 0132-0134). In re claim 6, Berman ‘850 teaches further comprising adjusting one or more acquisition parameters of the scanning (0123). In re claim 7, Berman ‘850 teaches wherein the one or more acquisition parameters include at least one of a focal length, frequency, or beam steering angle in relation to the tissue (0123). In re claim 8, Berman ‘850 teaches wherein the adjustment of the one or more acquisition parameters is based on anatomical data, user-specific tissue characteristics or image quality (0123). In re claim 9, Berman ‘850 teaches wherein the transducer is configured to direct the beam at the user's skin at two or more angles through electrical or mechanical beam steering (fig. 10a-d, 0125, 0127). In re claim 10, Berman ‘850 teaches wherein the transducer is configured to scan the tissue along the scan path by rotating or translating the transducer along more than one axis (fig. 10a-d, 0125, 0127). In re claim 11, Berman ‘850 teaches further comprising recording a position of the transducer (0125-0128, note that the step motor is monitoring the position of the transducer). In re claim 12, Berman ‘850 teaches further comprising coordinating acquisition of scans based on the position of the transducer (0125-0128). In re claim 13, Berman ‘850 teaches wherein the wearable housing includes a set of markings relative to the user's skin configured to guide the moving the transducer to a predefined second position in relation to the tissue (0134, needle holes). In re claim 14, Berman ‘850 teaches wherein the wearable housing comprises a flexible material configured to conform to the user's anatomical curvature (0130). In re claim 15, Berman ‘850 teaches further comprising adjusting the wearable housing to enclose a variable depth of tissue (0130, the dome encloses a variable depth, fig. 3). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 16 is/are rejected under 35 U.S.C. 103 as being unpatentable over Berman ‘850 in view of Sarvazyan; Armen Paruir (US 5,678,565, hereinafter Sarvazyan ‘565). In re claim 16, Berman ‘850 fails to teach further comprising adjusting a pressure applied to the tissue to provide elastosonography data. Sarvazyan ‘565 teaches further comprising adjusting a pressure applied to the tissue to provide elastosonography data (abstract, col. 3, lines 18-35; fig. 8, col. 7, lines 46-65; col. 8, lines 45-55). Hence, it would also have been prima facie obvious to one of ordinary skills in the art at the time of invention to modify the method/device of Berman ‘850 to include the features of Sarvazyassn ‘565 in order to provide early diagnostics of breast cancer.. Response to Arguments Applicant's arguments filed July 13, 2026 have been fully considered but they are not persuasive. In response to Applicant’s argument that: Berman's scanning device includes a C-Arm-tomography-transducer (40) and a 2D-Array- transducer (50) which are positioned on top of a dome (20) (Berman [0116], FIGs. 3, 5, 1Oa-d) and are incapable of being rotated axially relative to the scanning assembly. The 2D-Array-5 transducer is mechanically coupled to a C-arm tomographic arc (passim, Berman [0099], [0107], FIG. 3), where the C-arm-tomography-transducer is moved along a circular-track (71) (Berman [0091], FIGs. 3, 5, 10a-d). Movement of Berman's 2D-Array-transducer is moved relative to the C-arm tomographic arc by step-motor-assembly (80) which "drives the two transducers 40 and 50 over the dome 20" (Berman [0124-0127]). See page 5-6 The Examiner disagrees. Berman clearly teaches transducer 50 rotates in all direction and one of which must be axial direction. See fig. 10, para 0125-0128, 85 is axial rotation for transducer 50, note that transducer can be rotated in 85, 86, 87, which are x, y, z, direction and one of them could be the axial rotation, Applicant has failed to limit the scope of axial rotation. Note that as stated above, it is unclear what the metes and bounds of “wherein the transducer is rotated axially relative to the scanning assembly” are. How is axial direction defined? How is relative to scanning assembly being defined? In a 3D world, any axis can be axially relative to. Applicant has failed to limit the scope of axially relative with respect to a specific directional placement of the scanning assembly. Applicant has not limited the scope of scanning assembly and any relative direction. Hence, when Berman’s transducer 50 can be rotated in all x, y, z rotations, it reads on at least rotated axially relative to the scanning assembly. Applicant’s arguments with respect to claim(s) 16 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to BO JOSEPH PENG whose telephone number is (571)270-1792. The examiner can normally be reached Monday thru Friday: 8:00 AM-5:00 PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, ANNE M KOZAK can be reached at (571) 270-0552. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BO JOSEPH PENG/Primary Examiner, Art Unit 3797
Read full office action

Prosecution Timeline

Sep 05, 2024
Application Filed
Jan 13, 2026
Non-Final Rejection mailed — §102, §103, §112
Jul 13, 2026
Response Filed
Aug 10, 2026
Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778543
METHOD, A COMPUTER PROGRAM PRODUCT, AND A DEVICE FOR DETERMINING A CROSS-SECTIONAL WIDTH OF AN ARTERY
2y 0m to grant Granted Nov 03, 2026
Patent 12758798
ULTRASOUND AUTOFOCUSING FOR SHORT-PULSE PROCEDURES
2y 5m to grant Granted Oct 13, 2026
Patent 12745978
DEVICE FOR MEASURING OBSTRUCTION OF TRACHEOSTOMY TUBE, TRACHEA, AND BRONCHUS OF PATIENT WITH TRACHEOSTOMY TUBE
2y 1m to grant Granted Sep 29, 2026
Patent 12733991
FLUOROSCOPIC ROBOTIC PROSTHETIC IMPLANT SYSTEM AND METHODS
2y 1m to grant Granted Sep 15, 2026
Patent 12727847
CONTINUOUS BLOOD PRESSURE MEASUREMENT SYSTEM AND METHOD
1y 10m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
70%
Grant Probability
83%
With Interview (+13.7%)
3y 7m (~1y 5m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 780 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month